Earlier this year, the Busch Clinic added Profound Medical’s TULSA system to its treatment options. TULSA, also called “inside-out” ablation, uses a unique cooling system to provide thermal protection of important anatomy.
Pavan Khanna, MD, discusses the evolution of Y-90 for the treatment of HCC and reviews the LEGACY and DOSISPHERE trials, which highlight how TheraSphere™ is progressing Y-90 therapy towards more advanced dosimetry techniques and personalization.
Osman Ahmed, MD, FCIRSE, discusses the recently published LEGACY Study, which confirmed Boston Scientific’s TheraSphere™ as a neoadjuvant or standalone therapy in treating HCC.
IOL Radio Podcast: Dr Nora Tabori and Dr Riad Salem discuss LEGACY, a robust multicenter study confirming Boston Scientific’s TheraSphere™ as a neoadjuvant or standalone therapy in treating HCC.
In this video, Dr Ripal Gandhi discusses his experience with the TriNav™ Infusion System, including challenges, benefits, effectiveness, and more. Watch this short video to learn more about this simple, trackable, and compatible technology used…
Dr DeNittis discusses NuView Life Science’s VPAC1, a peptide platform that detects the overexpression of specific receptors that appear only on the surface of malignant cells for early diagnosis and therapy of cancer.
Backtable Podcast Episode #81: Interventional Radiologist Dr Eric Monroe from Seattle Children's walks us through Intra-Arterial Chemotherapy (IAC) for treatment of Retinoblastoma. In certain patients with retinoblastoma, IAC is a safe and effective…